Scientists have developed a method for analysing the structure of lipid nanoparticles that could be used to improve vaccine and drug delivery. 

A team led by scientists at the University of Nottingham’s School of Pharmacy demonstrated a new cryogenic mass spectrometry approach for depth profiling frozen lipid nanoparticles (LNPs) to reveal the layers and orientation of the constituent molecules. 

Areas of development for LNPs include lung-targeted gene therapy, as LPNs have the potential to treat a range of diseases including cystic fibrosis, idiopathic pulmonary fibrosis, chronic obstructive pulmonary disease, asthma and more. 

This research provides insight into the relative positions of each component within lipid nanoparticles. This knowledge can help clarify the intricate behaviour of LNPs and contribute to the design of formulations with unique bio-properties that are more efficient and safer.  

The research findings could also be used in the future to help quality control during the scale-up of manufacturing processes, enhancing the translation of LNPs from the laboratory to clinical applications. 

The research team which also included Sail Biomedicines, Cambridge, MA, Massachusetts Institute of Technology, Cambridge, MA and the National Physical Laboratory, Teddington UK, utilised Cryogenic Orbitrap secondary ion microscopy (Cryo-OrbiSIMS) to provide structural details of the lipid nanoparticles. This high pressure freezing cryo-preparation facility keeps biological samples maintained close to their native state. 

Professor Morgan Alexander, who led the research, explained: “Characterising the native surface of delicate hydrated pharmaceutical systems used in the body has been a significant challenge for some time. This cryogenic molecular surface and interfacial analysis advance makes this exciting possibility real. We expect to apply this new method to many systems, including lipid nanoparticles, other pharmaceutical delivery systems and hydrated biomaterials.”

Diana Spencer, Senior Digital Content Editor, DDW